TELO:Telomir Pharmaceuticals Inc Snapshot | Charting | News | Options
$2.28 NASDAQ 7:54a ET
May 22 '25 		Telomir Pharmaceuticals Secures $3 Million at a Premium in Straight Equity Sale Involving No Warrants to A... ACCESSWIRE
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Telomir Pharmaceuticals Secures $3 Million at a Premium in Straight Equity Sale Involving No Warrants to Advance Rare Disease IND
     ACCESSWIRE

    Investment from largest shareholder strengthens balance sheet, signals insider conviction, and funds Telomir-1's upcoming IND submission for a rare disease indication

    MIAMI, FLORIDA / ACCESSWIRE / May 21, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), an emerging leader in age-reversal science, today announced it has secured $3 million in equity financing, through a direct investment by The Bayshore Trust, the Company's largest shareholder.

    Full Story →

    Headline News
    More News →
    Day  88.4%Week  96.6%Month  29.5%More Charting →
    July 18 '25. Markets Closed.
    Last $2.28
    Day change   88.43%$1.07
    Open $3.055
    Gap at open $1.84
    Previous close $1.21
    Trading volume 137,205,810
    10 Day avg vol. 3,496,386
    Shares out. 29.8Mil
    Market cap. $67.9Mil
    Trading activity Above Avg.
    Previous data from yesterday, July 17 '25.

    Historical Price Performance
    3 month   8.06% 
    6 month   51.39% 
    1 year   41.39% 
    2 year   NA 
    NA = Not Available

    Earnings
    Previous 12m -$0.41
    Next 12m Estimate -$0.31
    P/E ratio --
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2025 All rights reserved.